NON-SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON-SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation technique aims to shield the heart during cancer treatment
Disease control Recruiting nowThis study is testing a new, more precise way to deliver radiation therapy for cancers in the chest area, like lung and esophageal cancer. The goal is to see if using real-time MRI guidance can better protect the heart from radiation damage compared to the standard method. Resear…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Blood test spots hidden cancer, guides new treatment to stop it returning
Disease control Recruiting nowThis study is for people with early-stage non-small cell lung cancer who have finished their standard treatment. It uses a special blood test to look for tiny leftover cancer signals. If the test is positive, participants receive a drug called durvalumab to try to clear these sig…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Virus therapy tested to fight lung cancer that stops responding to treatment
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer that has started to grow again after their first treatment with immunotherapy and chemotherapy. It compares a new two-part treatment—first a specially engineered virus given by IV, followed by standard chemotherapy…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New attack on tough lung cancer: shrink tumors first, then operate
Disease control Recruiting nowThis study is testing a specific treatment plan for people with a hard-to-treat form of advanced lung cancer that has spread to distant lymph nodes. The goal is to see if giving a combination of chemotherapy and immunotherapy drugs *before* surgery can shrink the cancer enough to…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Can a breathing rehab program ease the struggle for advanced lung cancer survivors?
Symptom relief Recruiting nowThis study is testing if an 8-week pulmonary rehabilitation program can help people who have survived advanced non-small cell lung cancer. The program includes exercise training and education, aiming to reduce shortness of breath and fatigue while improving quality of life. Resea…
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 18, 2026 14:40 UTC
-
Scientists track how cancer treatments work in real patients
Knowledge-focused Recruiting nowThis study aims to understand how the immune system responds to standard treatments for advanced lung cancer. Researchers will analyze blood and tumor samples from 50 patients who have already received chemotherapy, radiation, and immunotherapy as part of their regular care. The …
Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC